ArticleJournal for immunotherapy of cancer2020

Development and validation of a genomic mutation signature to predict response to PD-1 inhibitors in non-squamous NSCLC: a multicohort study

Xue Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.